2 results
Approved WMORecruiting
The objective of the study is to compare conventional therapy with biological therapy in patients with early rheumatoid arthritis.
Approved WMORecruiting
To investigate how safe the new medicine pralsetinib is when it is administered to patients with non-resectable advanced solid tumor cancers including non-small cell lung cancer (NSCLC) and Thyroid cancers.